# Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics

> **NCT02923336** · NA · UNKNOWN · sponsor: **ALDO TORRE DELGADILLO** · enrollment: 10 (estimated)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** non selective beta blocker

## Key facts

- **NCT ID:** NCT02923336
- **Lead sponsor:** ALDO TORRE DELGADILLO
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2019-01
- **Final completion:** 2021-05
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2019-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02923336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02923336, "Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT02923336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*